Evidence map›Paper›PMID 39847192›Full record

ArticleCognitive research: principles and implications2025

Delay discounting predicts COVID-19 vaccine booster willingness.

Julia G Halilova, Samuel Fynes-Clinton, Caitlin M Terao, Donna Rose Addis, R Shayna Rosenbaum

Abstract read
In one paragraph

Article in Cognitive research: principles and implications, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Julia G HalilovaDepartment of Psychology and Centre for Integrative and Applied Neuroscience, York University, 4700 Keele St., Toronto, ON, M3J 1P3, Canada.ORCID 0000-0003-4158-5108
Samuel Fynes-ClintonBaycrest Academy for Research and Education, Toronto, Canada.
Caitlin M TeraoDepartment of Psychology and Centre for Integrative and Applied Neuroscience, York University, 4700 Keele St., Toronto, ON, M3J 1P3, Canada.
Donna Rose Addis *Baycrest Academy for Research and Education, Toronto, Canada.
R Shayna Rosenbaum *Department of Psychology and Centre for Integrative and Applied Neuroscience, York University, 4700 Keele St., Toronto, ON, M3J 1P3, Canada. shaynar@yorku.ca.

Funding

CIHR grant 172681
6 · The paper itself

Abstract

Developing ways to predict and encourage vaccine booster uptake are necessary for durable immunity responses. In a multi-nation sample, recruited in June-August 2021, we assessed delay discounting (one's tendency to choose smaller immediate rewards over larger future rewards), COVID-19 vaccination status, demographics, and distress level. Participants who reported being vaccinated were invited back one year later (n = 2547) to report their willingness to receive a booster dose, along with reasons for their decision. After controlling for demographic variables and distress level, a greater tendency to discount future rewards was associated with reduced willingness to receive a booster dose. Thematic coding revealed that the most common reason for booster willingness was protection against COVID-19, and for unwillingness was non-necessity. The results identify delay discounting as a behavioral predictor of booster willingness that may be used to inform tailored approaches to increase booster uptake (e.g., trust in science vs. vaccine mandates).

Indexed as

COVID-19COVID-19 VaccinesDelay DiscountingImmunization, SecondaryPatient Acceptance of Health CareAdultFemaleHumansMaleMiddle AgedRewardYoung AdultCOVID-19 VaccinesDecision-makingImmunity maintenancePublic health measuresVaccine hesitancy

Identifiers

PMID39847192
PMCPMC11757841

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.